Diastolic dysfunction after an acute myocardial infarction in patients with antecedent hypertension

Niels Holmark Andersen1, Finn Michael Karlsen, Jens Christian Gerdes

  • 1Department of Cardiology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark. holmark@ki.au.dk

Insights

Patients with hypertension show impaired diastolic function recovery after myocardial infarction. Despite similar systolic function, their diastolic function did not improve as much as in non-hypertensive individuals.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Hypertension Research

Background:

  • Hypertension is a significant risk factor for cardiovascular disease.
  • Acute myocardial infarction (AMI) affects cardiac function.
  • The impact of antecedent hypertension on post-AMI cardiac recovery requires further investigation.

Purpose of the Study:

  • To evaluate changes in left ventricular systolic and diastolic function.
  • To compare recovery patterns in patients with and without antecedent hypertension after AMI.

Main Methods:

  • A cohort of 38 hypertensive patients with AMI was compared to age-matched controls.
  • Left ventricular volumes, ejection fraction, systolic velocities, and strain were assessed.
  • Diastolic function was evaluated using mitral inflow and mitral ring tissue velocities.

Main Results:

  • Hypertensive patients showed no significant improvement in E/E' or E'/A' ratios.
  • Control subjects demonstrated significant improvements in E/E' and E'/A' ratios.
  • These diastolic function differences persisted despite comparable changes in ejection fraction, volumes, and systolic strain.

Conclusions:

  • Antecedent hypertension is associated with incomplete recovery of diastolic function post-AMI.
  • Diastolic dysfunction recovery is impaired in hypertensive patients compared to controls.
  • Left ventricular volumes and ejection fraction recovery were similar between groups.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...